Search

everythinglearnresearchcommunity

for

Search:↓

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

The combination treatment showed a higher response rate but no significant survival benefits.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Removing a cat's pancreatic cancer can temporarily reverse hair loss caused by the disease.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Certain drugs that block specific enzymes can help treat prostate diseases.

Some cats with sudden hair loss and tiredness might have cancer-related alopecia.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Vitamin D is important for skin health and can affect various skin diseases.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document explains the diagnosis and characteristics of woolly hair nevus and alopecia neoplastica.

Cetuximab can cause excessive eyelash growth.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Radiation therapy for cancer often causes skin problems like redness, dryness, and pain.

Cetuximab can cause eyelash growth, which is rare but manageable.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Cetuximab can cause unusual hair growth and hair loss.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.